In both abetalipoproteinemia and familial homozygous hypobetalipoproteinemia the consequence of gene mutations is failure of release of ApoB-containing lipoproteins, especially chylomicrons and very low density lipoproteins (VLDL) (Burnett and Hooper, 2015). Here, APOB is linked to hypobetalipoproteinemia.